Sponsor
University of Oklahoma
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04928508
The purpose of this research is to test the safety of the study drug (OK-1) and see what effects (good and bad) this drug has on patients with recurrent solid tumors.
Intervention
OK-1
Condition
Solid Tumor, Adult
Investigators
Debra Richardson, MD, Ingrid Block, Lead Gynecology Oncology Nurse